---
title: 'Using machine learning approaches to develop a fast and easy-to-perform diagnostic
  tool for patients with light chain amyloidosis: a retrospective real-world study'
date: '2024-10-31'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39480584/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1T5FW5K6kI7Ui-YFfm6b8NuT1rAqMfZcYcvuOELhU7ZdLYMMmI&fc=20220727230845&ff=20241101195429&v=2.18.0.post9+e462414
source: (yan,xiaojing[Author]) AND (China medical university[Affiliation])
description: Immunoglobulin light chain (AL) amyloidosis is a severe disorder caused
  by the accumulation of amyloid fibrils, leading to organ failure. Early diagnosis
  is crucial to prevent irreversible damage, yet it remains a challenge due to nonspecific
  symptoms that often appear later in the disease progression. A retrospective study
  analyzed data collected from 133 AL amyloidosis patients and 271 non-AL patients
  with similar symptoms but different diagnoses between January 1st, 2017, and September
  ...
disable_comments: true
---
Immunoglobulin light chain (AL) amyloidosis is a severe disorder caused by the accumulation of amyloid fibrils, leading to organ failure. Early diagnosis is crucial to prevent irreversible damage, yet it remains a challenge due to nonspecific symptoms that often appear later in the disease progression. A retrospective study analyzed data collected from 133 AL amyloidosis patients and 271 non-AL patients with similar symptoms but different diagnoses between January 1st, 2017, and September ...